From 'perfect mix' to 'potion magique' - Regulatory T cells and anti-inflammatory cytokines as adjuvant targets [1]

Nature Reviews Microbiology

Volumn 6, Issue 1, 2008, Pages

  Bayry, Jagadeesh ^a,b   Flower, Darren R ^c   Tough, David F ^d   Kaveri, Srini V ^a,b  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 10 ANTIBODY; VACCINE; TOLL LIKE RECEPTOR;

ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; CD4+ CD25+ T LYMPHOCYTE; CELLULAR IMMUNITY; DENDRITIC CELL; DOWN REGULATION; DRUG EFFICACY; EXPERIMENTAL MODEL; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; LETTER; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; VACCINATION; VIRUS INFECTION; DRUG EFFECT; IMMUNOLOGY; NOTE;

ADJUVANTS, IMMUNOLOGIC; CYTOKINES; HUMANS; T-LYMPHOCYTES, REGULATORY; TOLL-LIKE RECEPTORS; VACCINES;

EID: 37349063212     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro1681-c1     Document Type: Letter

References (17)

1. Guy, B. The perfect mix: Recent progress in adjuvant research. Nature Rev. Microbiol. 5, 505-517 (2007).
2. Miyara, M. & Sakaguchi, S. Natural regulatory T cells: Mechanisms of suppression. Trends Mol. Med. 13, 108-116 (2007).
3. + regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature dendritic cells in vivo. J. Exp. Med. 198, 259-266 (2003).
4. Tang, Q. et al. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nature Immunol. 7, 83-92 (2006).
5. high regulatory T cells modulate myeloid but not plasmacytoid dendritic cells activation. J. Immunol. 176, 5293-5298 (2006).
6. + regulatory T cells. J. Immunol. 178, 4184-4193 (2007).
7. Caramalho, I. et al. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 197, 403-411 (2003).
8. + T regulatory cells. J. Immunol. 175, 8051-8059 (2005).
9. + T regulatory cells inhibit neutrophil function and promote their apoptosis and death. J. Immunol. 177, 7155-7163 (2006).
10. + T cell responses. J. Exp. Med. 198, 889-901 (2003).
11. + T-cell responses against herpes simplex virus type 1. J. Virol. 78, 13082-13089 (2004).
12. + regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J. Exp. Med. 194, 823-832 (2001).
13. Curiel, T. J. et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nature Med. 10, 942-949 (2004).
14. Li, B. et al. Vascular endotheliall growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy. Clin. Cancer Res. 12, 6808-6816 (2006).
15. Johnson, Z., Schwarz, M., Power, C. A., Wells, T. N. & Proudfoot, A. E. Multi-faceted strategies to combat disease by interference with the chemokine system. Trends Immunol. 26, 268-274 (2005).
16. Salerno-Goncalves, R. & Sztein, M. B. Cell-mediated immunity and the challenges for vaccine development. Trends Microbiol. 14, 536-542 (2006).
17. Das, L., DeVecchio, J. & Heinzel, F. P. Fms-like tyrosine kinase 3-based immunoprophylaxis against infection is improved by adjuvant treatment with anti-interleukin- 10 antibody. J. Infect. Dis. 192, 693-702 (2005).